Sukhtian Ghiath M.
SEC CIK 1717441 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Dir, 10% | 24.62M | $27.50M | — | 8 | 2021-11-29 | 2026-08-12 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-08-14 19:52 | 2026-08-12 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | P - Purchase | $0.99 | +2.53M | 24.62M | +11% | +$2.50M |
| DI | 2026-06-01 21:30 | 2026-05-28 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | P - Purchase | $0.5855 | +8.54M | 22.09M | +63% | +$5.00M |
| DI | 2025-05-28 | 2025-05-27 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | A - Grant | $1.40 | +4.29M | 13.55M | +46% | +$6.00M |
| AI | 2025-03-12 | 2025-01-17 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | M - OptEx | $2.51 | +3.46M | 9.27M | +60% | +$8.68M |
| DI | 2024-03-20 | 2024-03-18 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | A - Grant | — | +2.31M | 5.81M | +66% | — |
| I | 2022-12-29 | 2022-12-28 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | A - Grant | $0.88 | +14.23M | 70.05M | +25% | +$12.52M |
| AI | 2022-07-07 | 2022-04-21 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | J - Other | — | +27.98M | 55.82M | +101% | — |
| I | 2021-12-01 | 2021-11-29 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Dir, 10% | P - Purchase | $1.25 | +16.00M | 27.83M | +135% | +$20.00M |
Purchase Sale Sale after option exercise All abbreviations